Central counterparties for OTC derivatives: Neither panacea nor placebo

ISSN： 1753-1802

Source： Journal of Securities Operations & Custody, Vol.2, Iss.4, 2010-01, pp. : 294-303

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The systemic risks of OTC derivatives central clearing

By Murphy David

Journal of Risk Management in Financial Institutions, Vol. 5, Iss. 3, 2012-06 ,pp. : 319-334

Henry Stewart Publications

Access to resources Recommend Favorite

Trends in OTC derivatives

By Angle Corby

Journal of Securities Operations & Custody, Vol. 3, Iss. 1, 2010-05 ,pp. : 44-54

Henry Stewart Publications

Access to resources Recommend Favorite

OTC derivatives: How OTC will they be? A buy-side view

By Grosse-Nobis Kerstin

Journal of Securities Operations & Custody, Vol. 4, Iss. 4, 2012-05 ,pp. : 287-294

Henry Stewart Publications

Access to resources Recommend Favorite

The end of the waterfall: Default resources of central counterparties

Journal of Risk Management in Financial Institutions, Vol. 8, Iss. 4, 2015-10 ,pp. : 365-389

Henry Stewart Publications

Access to resources Recommend Favorite

Reforming the OTC credit derivatives market

By de Meijer Carlo

Journal of Securities Operations & Custody, Vol. 2, Iss. 3, 2010-01 ,pp. : 231-249

Henry Stewart Publications

Access to resources Recommend Favorite